Drug reference
tebentafusp
Drug monograph
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
An engineered bispecific fusion protein targeting gp100 on melanoma and CD3 on T cells.
Indications
treatment of metastatic uveal melanoma in patients who have the HLA-A*02.01 tissue type
Related guidelines
Other Unclassified drugs
Ask House about tebentafusp
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Harrison 22e·Verified: 2026-05-10 · House clinical team